Literature DB >> 18374880

Sex-specific predictive power of 6-minute walk test in chronic heart failure is not enhanced using percent achieved of published reference equations.

Lutz Frankenstein1, Christian Zugck, Manfred Nelles, Dieter Schellberg, Hugo Katus, Andrew Remppis.   

Abstract

BACKGROUND: The 6-minute walk test (6MWT) is an established prognostic tool in chronic heart failure. The strong influence of height, weight, age, and sex on 6MWT distance may be accounted for by using percentage achieved of predicted value rather than uncorrected 6MWT values.
METHODS: The study included 1069 patients (862 men) with a mean age 55.2 +/- 11.7 years and mean left ventricular ejection fraction of 29% +/- 10%, attending the heart failure clinic of the University of Heidelberg between 1995 and 2005. The predictive power and accuracy of 6MWT and achieved percentage values according to all available published equations for mortality and mortality or transplant combined were tested separately for each sex.
RESULTS: The percentage values varied largely between equations. For all equations, women in New York Heart Association (NYHA) functional class I had higher values than men. Although the 6MWT significantly discriminated all NYHA classes for both sexes, only 1 equation discriminated all NYHA classes. No significant differences in the area under the receiver operating-characteristic curve were noted between achieved percentage values and 6MWT. Despite strong univariate significance, achieved percentage values did not retain multivariate significance. The 6MWT was independent from N-terminal brain natriuretic propeptide, NYHA, left ventricular ejection fraction, and peak oxygen uptake.
CONCLUSION: We confirmed 6MWT to be a strong and independent risk predictor for both sexes. Because the prognostic power of 6MWT is not enhanced using percentage achieved of published reference equations, we suggest recalibration of these reference values rather than discarding this approach.

Entities:  

Mesh:

Year:  2008        PMID: 18374880     DOI: 10.1016/j.healun.2008.01.010

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  3 in total

1.  The 6MWT as a prognostic tool in pulmonary arterial hypertension: results from the COMPERA registry.

Authors:  Thomas A Zelniker; Dörte Huscher; Anton Vonk-Noordegraaf; Ralf Ewert; Tobias J Lange; Hans Klose; Daniel Dumitrescu; Michael Halank; Matthis Held; Henning Gall; David Pittrow; Marius M Hoeper; Lutz Frankenstein
Journal:  Clin Res Cardiol       Date:  2018-01-24       Impact factor: 5.460

2.  Ambulatory Advanced Heart Failure in Women: A Report From the REVIVAL Registry.

Authors:  Garrick C Stewart; Thomas Cascino; Blair Richards; Shokoufeh Khalatbari; Douglas L Mann; Wendy C Taddei-Peters; J Timothy Baldwin; Neal O Jeffries; Catherine Spino; Lynne W Stevenson; Keith D Aaronson
Journal:  JACC Heart Fail       Date:  2019-05-08       Impact factor: 12.035

3.  Physical functional performance and prognosis in patients with heart failure: a systematic review and meta-analysis.

Authors:  Iván José Fuentes-Abolafio; Brendon Stubbs; Luis Miguel Pérez-Belmonte; María Rosa Bernal-López; Ricardo Gómez-Huelgas; Antonio Ignacio Cuesta-Vargas
Journal:  BMC Cardiovasc Disord       Date:  2020-12-09       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.